Reassurance Against Future Risk of Precancer and Cancer Conferred by a Negative Human Papillomavirus Test

Primary human papillomavirus (HPV) testing (without concurrent Pap tests) every 3 years is under consideration in the United States as an alternative to the two recommended cervical cancer screening strategies: primary Pap testing every 3 years, or concurrent Pap and HPV testing (“cotesting”) every...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Gage, Julia C., Schiffman, Mark, Katki, Hormuzd A., Castle, Philip E., Fetterman, Barbara, Wentzensen, Nicolas, Poitras, Nancy E., Lorey, Thomas, Cheung, Li C., Kinney, Walter K.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2014
Pynciau:
Brief Communication
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4111283/
https://ncbi.nlm.nih.gov/pubmed/25038467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/dju153
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg